Ebook: Top challenges in HTA

Email address:

First name:

Last name:

Job title:

Company name:

Country:

I work for

Please specify your industry *

Mobile number:

What is your role?

Unfortunately the document is not available at this current time, however if you leave your details we'll get it to you as soon as we can.

Please fill in all the information requested. It is very important you enter this information correctly so we can contact you with the document.

Remember my details Information

Remember my details

We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details

close »

With a growing number of countries using HTA to make decisions, what are the different evidence requirements? In Europe, to enhance cooperation between countries, there are initiatives to facilitate efficient use of HTA resources, knowledge sharing and promote good practice in HTA methods and processes.

In this ebook, we present some thoughts from industry individuals on the current challenges in health technology assessment.

Learn from:

Alicia Granados MD PhD PH, Head of Global Evidence Definition/ Health Technology Assessment, EVD Global Medical Affairs, Genzyme
Dr Timm Volmer, Managing Partner, SmartStep Consulting GmbH
Dr Tobias Gantner, Vice President, Head Market Access Europe, Alimera Sciences
Vitaly Omelyanovskiy, Director of Centre for Health Technology Assessment, Russian Presidential Academy of National Economy and Public Administration (RPANEPA)
Dr. Julia Schmitz, Pharmaceuticals Department, Gemeinsamer Bundesausschuss